|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal Susitarimą)
| (51) | INT.CL. | A61K 31/205 | |
| C09K 3/30 | |||
| A61K 9/14 | |||
| A61K 9/00 |
| (11) | Patento numeris | 2292584 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 10176026.2 |
| Europos patento paraiškos padavimo data | 2003-12-08 | |
| (97) | Europos patento paraiškos paskelbimo data | 2011-03-09 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2017-03-01 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 432195 P | 2002-12-10 | US |
| (72) |
McGlynn, Paul, US
Bakale, Roger, US
Sturge, Craig, CA
|
| (73) |
Sunovion Pharmaceuticals Inc.,
84 Waterford Drive, Marlborough, MA 01752,
US
|
| (54) | Pharmaceutical composition comprising Levalbuterol L-hemitartrate salt as aerosol formulation |
| Pharmaceutical composition comprising Levalbuterol L-hemitartrate salt as aerosol formulation |